Download PDF
Klin Monbl Augenheilkd 2011; 228(5): 419-424
DOI: 10.1055/s-0031-1273325
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Diagnose und Therapie der Skleritis bei entzündlichen Systemerkrankungen

Diagnosis and Treatment of Scleritis Associated to Inflammatory Systemic DiseasesC. Tappeiner1 , A. Heiligenhaus2
  • 1Universitätsklinik für Augenheilkunde, Inselspital, Universität Bern
  • 2Augenabteilung am St. Franziskus Hospital, Münster; Universität Essen
Further Information

Publication History

Eingegangen: 1.1.2011

Angenommen: 21.3.2011

Publication Date:
29 April 2011 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Aufgrund potenziell visusbedrohender Komplikationen und der Assoziation zu Systemerkrankungen mit einer erhöhten Mortalität sind bei Skleritiden eine gezielte Diagnostik und eine frühzeitige und aggressive entzündungshemmende Systemtherapie notwendig. Neue therapeutische Optionen (wie z. B. Biologica) können in ansonsten therapieresistenten Fällen eine Remission erzielen.

Abstract

Because of potential vision-threatening complications and the association to inflammatory systemic diseases with an increased mortality, scleritis patients need an adequate diagnostic work-up and early and aggressive anti-inflammatory systemic treatment. New therapeutic options (such as biologicals) help to achieve remission in otherwise refractory cases.

Schlüsselwörter

Skleritis - Diagnose - Therapie

Key words

scleritis - diagnosis - treatment

Literatur

  • 1 Okhravi N, Odufuwa B, McCluskey P et al. Scleritis.  Surv Ophthalmol. 2005;  50 351-363
    Google Scholar
  • 2 Sainz de la Maza M, Jabbur N S, Foster C S. Severity of scleritis and episcleritis.  Ophthalmology. 1994;  101 389-396
    Google Scholar
  • 3 Jabs D A, Rosenbaum J T, Foster C S et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.  Am J Ophthalmol. 2000;  130 492-513
    Google Scholar
  • 4 Albini T A, Rao N A, Smith R E. The diagnosis and management of anterior scleritis.  Int Ophthalmol Clin. 2005;  45 191-204
    Google Scholar
  • 5 Rachitskaya A, Mandelcorn E D, Albini T A. An update on the cause and treatment of scleritis.  Curr Opin Ophthalmol. 2010;  21 463-467
    Google Scholar
  • 6 Sainz de la Maza M, Foster C S, Jabbur N S. Scleritis associated with systemic vasculitic diseases.  Ophthalmology. 1995;  102 687-692
    Google Scholar
  • 7 Raiji V R, Palestine A G, Parver D L. Scleritis and systemic disease association in a community-based referral practice.  Am J Ophthalmol. 2009;  148 946-950
    Google Scholar
  • 8 Afshari N A, Afshari M A, Foster C S. Inflammatory conditions of the eye associated with rheumatic diseases.  Curr Rheumatol Rep. 2001;  3 453-458
    Google Scholar
  • 9 Bullen C L, Liesegang T J, McDonald T J et al. Ocular complications of Wegener’s granulomatosis.  Ophthalmology. 1983;  90 279-290
    Google Scholar
  • 10 Isaak B L, Liesegang T J, Michet Jr C J. Ocular and systemic findings in relapsing polychondritis.  Ophthalmology. 1986;  93 681-689
    Google Scholar
  • 11 Tuft S J, Watson P G. Progression of scleral disease.  Ophthalmology. 1991;  98 467-471
    Google Scholar
  • 12 Foster C S. Immunosuppressive therapy for external ocular inflammatory disease.  Ophthalmology. 1980;  87 140-150
    Google Scholar
  • 13 Watson P G, Hayreh S S. Scleritis and episcleritis.  Br J Ophthalmol. 1976;  60 163-191
    Google Scholar
  • 14 Rao N A, Marak G E, Hidayat A A. Necrotizing scleritis. A clinico-pathologic study of 41 cases.  Ophthalmology. 1985;  92 1542-1549
    Google Scholar
  • 15 Hemady R, Sainz de la Maza M, Raizman M B et al. Six cases of scleritis associated with systemic infection.  Am J Ophthalmol. 1992;  114 55-62
    Google Scholar
  • 16 Feiz V, Redline D E. Infectious scleritis after pars plana vitrectomy because of methicillin-resistant Staphylococcus aureus resistant to fourth-generation fluoroquinolones.  Cornea. 2007;  26 238-240
    Google Scholar
  • 17 Howell A, Midturi J, Sierra-Hoffman M et al. Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.  Med Mycol. 2005;  43 651-655
    Google Scholar
  • 18 Huang F C, Huang S P, Tseng S H. Management of infectious scleritis after pterygium excision.  Cornea. 2000;  19 34-39
    Google Scholar
  • 19 Hwang Y S, Chen Y F, Lai C C et al. Infectious scleritis after use of immunomodulators.  Arch Ophthalmol. 2002;  120 1093-1094
    Google Scholar
  • 20 Meyer J J, Espandar L, Marx D P et al. Pseudomonas scleritis resistant to fourth-generation fluoroquinolones in a patient without prior trauma or surgery.  Ocul Immunol Inflamm. 2008;  16 127-129
    Google Scholar
  • 21 Moreno Honrado M, del Campo Z, Buil J A. A case of necrotizing scleritis resulting from Pseudomonas aeruginosa.  Cornea. 2009;  28 1065-1066
    Google Scholar
  • 22 Rich R M, Smiddy W E, Davis J L. Infectious scleritis after retinal surgery.  Am J Ophthalmol. 2008;  145 695-699
    Google Scholar
  • 23 Seth R K, Gaudio P A. Nocardia asteroides necrotizing scleritis associated with subtenon triamcinolone acetonide injection.  Ocul Immunol Inflamm. 2008;  16 139-140
    Google Scholar
  • 24 Bhat P V, Jakobiec F A, Kurbanyan K et al. Chronic herpes simplex scleritis: characterization of 9 cases of an underrecognized clinical entity.  Am J Ophthalmol. 2009;  148 779-789
    Google Scholar
  • 25 Jain V, Shome D, Natarajan S et al. Surgically induced necrotizing scleritis after pterygium surgery with conjunctival autograft.  Cornea. 2008;  27 720-721
    Google Scholar
  • 26 Morley A MS, Pavesio C. Surgically induced necrotising scleritis following three-port pars plana vitrectomy without scleral buckling: a series of three cases.  Eye. 2008;  22 162-164
    Google Scholar
  • 27 Nguyen D Q, Raman V S, Twomey J M et al. Keratectasia as a presentation of surgically induced necrotizing sclerokeratitis (SINS).  Eye Contact Lens. 2007;  33 332-333
    Google Scholar
  • 28 Sainz de la Maza M, Foster C S. Necrotizing scleritis after ocular surgery. A clinicopathologic study.  Ophthalmology. 1991;  98 1720-1726
    Google Scholar
  • 29 Salacz G. Postoperative necrotizing sclerokeratitis.  Doc Ophthalmol. 1992;  80 167-170
    Google Scholar
  • 30 O’Donoghue E, Lightman S, Tuft S et al. Surgically induced necrotising sclerokeratitis (SINS) – precipitating factors and response to treatment.  Br J Ophthalmol. 1992;  76 17-21
    Google Scholar
  • 31 McCluskey P J, Watson P G, Lightman S et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients.  Ophthalmology. 1999;  106 2380-2386
    Google Scholar
  • 32 Sen H N, Sangave A, Hammel K et al. Infliximab for the treatment of active scleritis.  Can J Ophthalmol. 2009;  44 e9-e12
    Google Scholar
  • 33 Doctor P, Sultan A, Syed S et al. Infliximab for the treatment of refractory scleritis.  Br J Ophthalmol. 2010;  94 579-583
    Google Scholar
  • 34 Ahn S J, Oh J Y, Kim M K et al. Treating refractory scleritis with infliximab.  Jpn J Ophthalmol. 2009;  53 286-287
    Google Scholar
  • 35 Kontkanen M, Paimela L, Kaarniranta K. Regression of necrotizing scleritis in Wegener’s granulomatosis after infliximab treatment.  Acta Ophthalmol. 2010;  88 e96-e97
    Google Scholar
  • 36 Restrepo J P, Molina M P. Successful treatment of severe nodular scleritis with adalimumab.  Clin Rheumatol. 2010;  29 559-561
    Google Scholar
  • 37 Kurz P A, Suhler E B, Choi D et al. Rituximab for treatment of ocular inflammatory disease: a series of four cases.  Br J Ophthalmol. 2009;  93 546-548
    Google Scholar
  • 38 Chauhan S, Kamal A, Thompson R N et al. Rituximab for treatment of scleritis associated with rheumatoid arthritis.  Br J Ophthalmol. 2009;  93 984-985
    Google Scholar
  • 39 Taylor S RJ, Salama A D, Joshi L et al. Rituximab is effective in the treatment of refractory ophthalmic Wegener’s granulomatosis.  Arthritis Rheum. 2009;  60 1540-1547
    Google Scholar
  • 40 Benson W E. Posterior scleritis.  Surv Ophthalmol. 1988;  32 297-316
    Google Scholar
  • 41 Sainz de la Maza M, Jabbur N S, Foster C S. An analysis of therapeutic decision for scleritis.  Ophthalmology. 1993;  100 1372-1376
    Google Scholar
  • 42 Singh G, Guthoff R, Foster C S. Observations on long-term follow-up of posterior scleritis.  Am J Ophthalmol. 1986;  101 570-575
    Google Scholar
  • 43 Calthorpe C M, Watson P G, McCartney A C. Posterior scleritis: a clinical and histological survey.  Eye. 1988;  2 (Pt 3) 267-277
    Google Scholar
  • 44 Chaques V J, Lam S, Tessler H H et al. Computed tomography and magnetic resonance imaging in the diagnosis of posterior scleritis.  Ann Ophthalmol. 1993;  25 89-94
    Google Scholar
  • 45 Watson P G. Anterior segment fluorescein angiography in the surgery of immunologically induced corneal and scleral destructive disorders.  Ophthalmology. 1987;  94 1452-1464
    Google Scholar
  • 46 Watson P G. Doyne Memorial Lecture, 1982. The nature and the treatment of scleral inflammation.  Trans Ophthalmol Soc U K. 1982;  102 (pt 2) 257-281
    Google Scholar
  • 47 Heiligenhaus A, Schilling M, Lung E et al. Ultrasound biomicroscopy in scleritis.  Ophthalmology. 1998;  105 527-534
    Google Scholar
  • 48 Fong L P, Sainz de la Maza M, Rice B A et al. Immunopathology of scleritis.  Ophthalmology. 1991;  98 472-479
    Google Scholar
  • 49 Kafkala C, Daoud Y J, Paredes I et al. Masquerade scleritis.  Ocul Immunol Inflamm. 2005;  13 479-482
    Google Scholar
  • 50 Soukiasian S H, Foster C S, Niles J L et al. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener’s granulomatosis.  Ophthalmology. 1992;  99 125-132
    Google Scholar
  • 51 Jabs D A, Mudun A, Dunn J P et al. Episcleritis and scleritis: clinical features and treatment results.  Am J Ophthalmol. 2000;  130 469-476
    Google Scholar
  • 52 Gangaputra S, Newcomb C W, Liesegang T L et al. Methotrexate for ocular inflammatory diseases.  Ophthalmology. 2009;  116 2188-2198
    Google Scholar
  • 53 Pasadhika S, Kempen J H, Newcomb C W et al. Azathioprine for ocular inflammatory diseases.  Am J Ophthalmol. 2009;  148 500-509
    Google Scholar
  • 54 Daniel E, Thorne J E, Newcomb C W et al. Mycophenolate mofetil for ocular inflammation.  Am J Ophthalmol. 2010;  149 423-432
    Google Scholar
  • 55 Kaçmaz R O, Kempen J H, Newcomb C et al. Cyclosporine for ocular inflammatory diseases.  Ophthalmology. 2010;  117 576-584
    Google Scholar
  • 56 Iaccheri B, Androudi S, Bocci E B et al. Rituximab treatment for persistent scleritis associated with rheumatoid arthritis.  Ocul Immunol Inflamm. 2010;  18 223-225
    Google Scholar
  • 57 Albini T A, Zamir E, Read R W et al. Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis.  Ophthalmology. 2005;  112 1814-1820
    Google Scholar
  • 58 Roufas A, Jalaludin B, Gaskin C et al. Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis.  Br J Ophthalmol. 2010;  94 743-747
    Google Scholar
  • 59 Sohn E H, Wang R, Read R. Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for nonnecrotizing, noninfectious anterior scleritis.  Ophthalmology. (in press)
    Google Scholar
  • 60 Zamir E, Read R W, Smith R E et al. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis.  Ophthalmology. 2002;  109 798-805 ; discussion 805 – 797
    Google Scholar
  • 61 Jabs D A. Discussion.  Ophthalmology. 2002;  109 806-807
    Google Scholar
  • 62 Fraunfelder F T, Watson P G. Evaluation of eyes enucleated for scleritis.  Br J Ophthalmol. 1976;  60 227-230
    Google Scholar
  • 63 Cordero-Coma M, Franco-Benito M, García-Ruiz-de-Morales J M et al. Successful treatment of surgically induced necrotizing sclerokeratitis (SINS) with systemic immunosuppresive agents and amniotic membrane grafting.  Arch Soc Esp Oftalmol. 2009;  84 577-580
    Google Scholar
  • 64 Sainz de la Maza M, Tauber J, Foster C S. Scleral grafting for necrotizing scleritis.  Ophthalmology. 1989;  96 306-310
    Google Scholar

Dr. Christoph Tappeiner

Universitätsklinik für Augenheilkunde, Inselspital

Freiburgstr. 10

3010 Bern

Schweiz

Phone: ++ 41/31/6 32 85 03

Fax: ++ 41/31/3 82 47 79

Email: christoph.tappeiner@insel.ch